Price History
Feb 9, 2026 — May 15, 2026Investment Snapshot
- P/E of 3.9 — trading at a low earnings multiple
- Piotroski F-Score 4/9 — moderate financial health
- Negative net margin (-481.2%) — currently unprofitable
- Revenue declining 55% annually
SciSparc Ltd. - Ordinary Shares (SPRC) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $2 million . Key value metrics: P/E ratio 3.9, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Revenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
SciSparc Ltd. - Ordinary Shares — Fundamental Analysis Summary
SciSparc Ltd. - Ordinary Shares (SPRC) trades at a trailing P/E of 3.9x — 85% below the Healthcare sector average of 25.2x.
StockPik's composite Value Score for SPRC is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SPRC reports a moderate gross margin of 38.7% (sector average: 40.1%) and a negative operating margin of -560.2%.
SPRC shows revenue declining at 55% year-over-year, with earnings declining at 23%.